Vectors Research Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,000
Closed -$18K 515
2022
Q2
$18K Buy
+6,000
New +$18K ﹤0.01% 297
2022
Q1
Sell
-6,000
Closed -$20K 604
2021
Q4
$20K Buy
6,000
+1,000
+20% +$3.33K ﹤0.01% 342
2021
Q3
$18K Hold
5,000
﹤0.01% 319
2021
Q2
$22K Buy
+5,000
New +$22K 0.01% 308